Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

Clinical trial NCT03613428 · UNKNOWN

Trial details

NCT number: NCT03613428
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute T Cell Leukemia

Start date: 2018-12-01
Primary completion: 2020-12-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.